Skip to main content

D. E. Shaw & Co., Inc.

Position in CORT — Corcept Therapeutics Inc

CIK 1009207 New York, NY

Position in CORT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$76,776,936
+$29,156,799 QoQ
Shares Held
883,001
-25.3% QoQ
Ownership
0.817%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#17
of 423 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CORT Over Time

Shares Held

Position Value (USD)

Derivatives in CORT

reported options exposure · as of Sep 30, 2025
CallValue
$0
CallShares
0
PutValue
$3,739,950
PutShares
45,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

D. E. Shaw & Co., Inc. holds $5,017,559,982 across 217 Biotechnology names. CORT ranks #18 (1.5% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CORT

Export CSV
27 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $76,776,936 883,001
2026-03-31 $47,620,137 1,181,348
2025-12-31 $5,904,411 169,667
2025-09-30 $48,544,384 584,098
2025-09-30 $3,739,950 45,000
2025-06-30 $49,408,255 673,137
2025-03-31 $79,984,153 700,264
2024-12-31 $44,674,563 886,576
2024-09-30 $36,471,601 788,064
2024-06-30 $30,837,655 949,143
2024-03-31 $28,542,385 1,133,084
2023-12-31 $53,872,561 1,658,638
2023-09-30 $41,368,415 1,518,107
2023-06-30 $25,579,689 1,149,649
2023-03-31 $16,985,749 784,199
2022-12-31 $24,216,790 1,192,358
2022-09-30 $41,327,166 1,611,824
2022-06-30 $38,319,567 1,611,420
2022-03-31 $25,193,370 1,118,711
2021-12-31 $7,796,210 393,748
2021-09-30 $4,441,323 225,677
2021-06-30 $3,010,832 136,856
2021-03-31 $6,782,932 285,117
2020-12-31 $14,172,415 541,759
2020-09-30 $7,409,120 425,567
2020-06-30 $5,462,361 324,754
2020-03-31 $3,379,577 284,237